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Abstract 
Objectives: This exploratory study examined the association between exposure to stressful life 
events (SLEs), polymorphisms (rs165774 and rs4680) in the catechol-O-methyltransferase 
COMT gene, and risk of depression in women. Methods: A cross-sectional design gathered 
information from 150 Australia women, aged 60-70 years, on socio-demographics, SLEs, and 
depressive symptoms. Participants also provided buccal cell swabs for genetic analysis. Results: 
Among women exposed to stressful life events, the odds of depressive symptoms increased by 
20% with each additional exposure (95% CI 1.06–1.34, p = 0.003). Women who carried at least 
one ‘A’ allele (AA/AG) for both rs165774 and rs4680 SNPs were less likely to report depressive 
symptoms (compared with women with the GG genotype. Moderation analysis did not support 
the hypotheses of an interaction with SLEs (rs165774, OR = 1.13, 95% CI 0.87–1.46, p = 0.347; 
rs4680, OR = 1.15 95% CI 0.91–1.44, p = 0.238). Conclusion: Our research suggests that 
women with polymorphisms in COMT were less susceptible to depressive symptoms but 
polymorphism do not appear to influence susceptibility to depression in those exposed to life 
stressors. Further research should consider other genetic variants in catecholamine pathways and 
their potential impact on women’s mental health. 
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Introduction 
Studies on the susceptibility to depressive illness have linked polymorphisms in several 
genes with a range of neuropsychiatric conditions (Doornbos et al. 2009; Drachmann Bukh et al. 
2009). One gene implicated in a number of  mental health disorders including depression is 
catechol-O-methyltransferase (COMT), a gene which regulates catecholamine’s like dopamine, 
epinephrine, and norepinephrine in the brain (Gogos et al. 1998). Among individuals with 
specific COMT genotypes and a history of stressful life events, polymorphisms might increase 
their risk of developing anxiety spectrum disorders, depressive illness, obsessive compulsive 
disorder, schizophrenia or alcohol dependence (Mandelli et al. 2007; Hettema et al. 2008; Wray 
et al. 2008; Voisey et al. 2011; Voisey et al. 2012).   Our understanding of these interactions is 
limited despite the growing evidence that inter-individual genetic variability can moderate an 
individual’s vulnerability or resilience to the effects of stressful life events (SLEs) and 
subsequent mental health problems (Kendler et al. 2010). In this exploratory study, we examine 
the influence of two SNPs encoded on the COMT gene (rs165774 and rs4680) and risk of 
depressive symptoms in older Australian women with and without a history of past SLE 
exposure.  
 
Methods 
Sample 
This paper presents the 2012 cross-sectional data from 150 women from the Healthy 
Aging of Women (HOW) study, recruitment strategies, response rates and methodological 
considerations have been detailed elsewhere (Seib et al. 2013a; Seib et al. 2013b). Briefly, a 
random sample of women aged 45 to 60, from high- and low- income, rural and urban areas of 
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South-East Queensland participated in a postal survey in 2001 and were followed up every 5 
years. Ethics approval for the project was obtained from the Human Research Ethics Committee 
of the Queensland University of Technology (Ethical approval number 1100000171).   
Measurement 
Self-administered postal questionnaires collected data on socio-demographic 
characteristics, lifestyle exposure to stressful life events ( LSC-R, range 0-30; (Wolfe and 
Kimerling 1997)) and depressive symptoms ( CES-D; (Radloff 1977)).  For this analysis, the 
CESD was also categorized to form a dichotomous variable indicating the presence of depressive 
symptoms (scores 0-15 representing no or few depressive symptoms and scores ≥ 16 suggesting 
some depressive symptoms; (Radloff 1977)).  
DNA was extracted from buccal cell swabs using a Gentra Puregene Buccal Cell Kit, 
(QIAGEN, Hilden, Germany) and DNA integrity and concentration in each sample was analyzed 
using a Nanodrop 1000 spectrophotometer (Thermo Fisher, Scoresby, VIC, Australia). DNA 
samples were sent to the Australian Genome Research Facility for genotyping using a 
homogeneous MassEXTEND (hME) Sequenom assay (Oeth et al. 2009). The hME assay is 
based on the annealing of an oligonucleotide primer (hME primer) adjacent to the SNP of 
interest.  The addition of a DNA polymerase along with a mixture of terminator nucleotides 
allows extension of the hME primer through the polymorphic site and generates allele-specific 
extension products, each having a unique molecular mass.  The resultant masses of the extension 
products are then analyzed by matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) and a genotype is assigned in real time. The hME assay was 
performed in multiplex with up to 36 reactions in a single well.   
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The genotyping failure rate was 1% for rs165774 (n = 2) and 0% for rs4680 (n = 0) for all 
included women. Genotypes were determined by investigators who were unaware of concurrent 
health status, or exposure to stressors.  
Statistical analysis 
This analysis used SPSS version 19 to examine the odds of depressive symptoms in 
women of different genotypes with and without a history of stressful life events(Statistics 2010). 
The adequacy of regression models were explored using several criteria: (1) a non-significant 
Hosmer-Lemeshow (H-L) goodness-of-fit χ2 test; a high predicted probability percentage for 
correct group classification, and; (3) Nagelkerke’s R2  ≥ .5; and, the likelihood ratio χ2 test (LR 
test statistic) which estimated the addition of a variable (or in this instance the interaction term) 
significantly contributed to the model (p <0.05).   
For the genetic analysis ethnicity needs to be considered and typically ethnically diverse 
samples would be analyzed in separate ethnic groups. The small sample size prevented these 
women from being analyzed separately and so 13 women removed from the analysis. The final 
sample included only Australian born, non-Indigenous women (N = 148). Hardy-Weinberg 
equilibrium (HWE) was computed using Utility Programs for Analysis of Genetic Linkage (Ott 
1988). Genotype frequencies indicated that the COMT polymorphisms (rs165774 and rs4680) 
were in Hardy-Weinberg equilibrium (χ2 = 0.001, p = 0.997 and χ2 = 0. 521, p = 0.481 
respectively).  
Due to the high correlation between rs165774 and rs4680 (i.e., D’ = 1.0, r2 = 0.5 
[www.HapMap.org, CEU]), the tests were non-independent and thus a Bonferroni correction 
could not be applied.  
Results 
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Women with depressive symptoms also reported more life stressors compared with women with 
few or no depressive symptoms (mean ± SD: 6.6 ± 3.2 and 4.5 ± 3.2 respectively; t = -3.42, p 
=0.001) and these results suggested that for every additional stress exposure, the odds of 
depressive symptoms increased by 20% (95% CI 1.06–1.35, p= 0.002). Odds ratios (OR) and 
95% confidence intervals (95% CI) were used to examine the relationship between depressive 
symptoms, exposure to life stressors, and SNPs rs165774 and rs4680 encoded on the COMT 
gene (see model 1, table 1). Results suggested that women who carried at least one ‘A’ alleles for 
rs165774 and rs4680 had a lower odds of depressive symptoms (OR = 0.36, 95% CI 0.16–0.85, p 
= 0.019 and OR = 0.41, 95% CI 0.18–0.95, p = 0.037 respectively) compared with women with 
the GG genotype.  
Moderation analysis was performed to explore potential interactions between COMT 
polymorphisms, stress exposure, and risk of depressive symptoms (see model 2, table 1). In this 
sample, no significant interactions were noted and LR test statistics suggested that the addition of 
the interaction terms did not contribute to the model (rs165774, χ 2 =0.91, p = 0.341; rs4680, χ 2 
=1.35, p = 0.244). On this basis model 1, the more parsimonious model, was determined to be 
the better fit for the data. Moreover, fit indices suggested the data were an adequate fit; The 
overall classification percentage suggested that model 1 correctly classified 73.8% of cases 
(probability of correct classification) for rs165774 and 75.2% of cases for rs4680 and the H-L 
goodness-of-fit tests were non-significant (rs165774: χ 2 = 46.95, p = 0.434; rs4680: χ 2 = 10.32, 
p = 0.243). In contrast, the models provided Nagelkerke’s R 2 of 0.156 and 0.123 respectively, 
suggesting only a modest relationship between prediction and grouping.  
[Insert table 1 about here] 
 
8  SEIB ET AL. 
 
Discussion 
This exploratory study examined the correlations between stressful life events, depressive 
symptoms, and two polymorphisms on the COMT gene, a gene associated with dopamine 
activity. Our results suggest that two polymorphisms on COMT might the decrease risk of 
depression adding support to the notion that inter-individual variability could influence an 
individual’s propensity towards depressive symptoms. These findings are supported by others 
who have suggested that although depression is frequently associated with environmental causes, 
the heterogeneity in individuals’ responses suggests differences in depressive symptoms are 
possibly attributable to genetic variation (Caspi and Moffitt 2006).  
Interestingly, results from this study did not support the hypothesis that genetic variations 
on COMT might influence vulnerability to depressive symptoms in those exposed to stressful life 
events. Indeed, moderation analysis suggested that though polymorphisms encoded on the 
COMT gene might be protective against depressive symptoms, the variations do not appear to 
influence the strength of the relationship between variables. Results also suggest that the 
polymorphisms on rs4680 and rs165774 are perhaps less influential in the face of adversity. 
These results are in contrast with others who have suggested that SNPs encoded on the COMT 
gene are associated with resilience in response to stress (Heinz and Smolka 2006; Feder et al. 
2009).  
Several limitations associated with this exploratory study should be mentioned. First, the 
cross-sectional study design was unable to examine cause and effect but did allow correlations to 
be explored. Second, although participants were obtained through random sampling in 2001, a 
proportion of women were lost-to-follow-up over time. Attrition may have impacted on the study 
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participant’s characteristics over time (discussed elsewhere, Seib 2013a, 2013b) and prevented 
more detailed subgroups and effect modification analyses.  
Despite these limitations, genotype frequencies of our available sample were similar to 
the HapMap CEU (European) data showed no significant differences between observed and 
expected genotype frequencies among participants. Moreover, our preliminary research suggests 
that variation in the COMT gene is associated with resilience to depressive symptoms but 
polymorphism do not appear to influence susceptibility to depression in women exposed to life 
stressors. Future research is needed to validate our findings and should also examine possible 
interactions between other genetic variations, exposure to stress and risk of depression in 
women, specifically in relation to catecholamine pathways and their potential impact on 
women’s mental health. 
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TABLE 1. ODDS RATIOS AND CONFIDENCE INTERVALS FOR DEPRESSIVE 
SYMPTOMS BY EXPOSURE TO STRESS AND GENOTYPE 
 Model 1 Model 2 
 OR (95% CI) p- value OR (95% CI) p- value 
rs165774     
LSC-R 1.20 (1.06–1.35) 0.003 1.15 (1.00–1.32) 0.045 
AA/AG 0.36 (0.16–0.85) 0.019 0.17 (0.03–1.05) 0.056 
rs165774 x LSC-R    1.13 (0.87–1.46) 0.347 
Likelihood ratio χ2 test   0.91, df = 1 0.341 
rs4680     
LSC-R 1.20 (1.06–1.35) 0.003 1.10 (0.92–1.31) 0.313 
AA/AG 0.41 (0.18–0.95) 0.037 0.19 (0.04–0.89) 0.035 
rs4680 x LSC-R   1.15 (0.91–1.44) 0.238 
Likelihood ratio χ2 test   1.35, df = 1 0.244 
 
LSC-R, Life Stressor Checklist - Revised (Wolfe and Kimerling 1997); OR, Odds Ratio; CI, 
Confidence Interval; rs165774 HapMap release #28 CEU (European) genotype frequencies are 
0.115 (AA), 0.398 (AG), 0.487 (GG); rs4680 HapMap CEU (European) genotype frequencies 
are 0.248 (AA), 0.460 (AG), 0.292 (GG). 
 
 
 
 
